The expression of HTRA3 has been found to be diminished or even lost in several cancer cell lines and tumors [10], which was associated with poor response to chemotherapeutic treatment and higher risk of postoperative recurrence in patients with lung cancer [36,37]. This evidence concerns the gene HTRA3 and cancer.